Previous Article | Next Article 
Infect Immun, July 1998, p. 3317-3325, Vol. 66, No. 7
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
The pH of the Host Niche Controls Gene Expression
in and Virulence of Candida albicans
Flavia
De Bernardis,1
Fritz A.
Mühlschlegel,2
Antonio
Cassone,1 and
William A.
Fonzi3,*
Laboratory of Bacteriology and Medical
Mycology, Instituto Superiore di Sanita, 00161 Rome,
Italy1;
Institut für Hygiene
und Mikrobiologie, Universität Würzburg, 97080 Würzburg, Germany2; and
Department of Microbiology and Immunology, Georgetown
University, Washington, D.C. 20007-21973
Received 2 February 1998/Returned for modification 20 February
1998/Accepted 17 April 1998
 |
ABSTRACT |
Little is known of the biological attributes conferring
pathogenicity on the opportunistic fungal pathogen Candida
albicans. Infection by this pathogen, as for bacterial pathogens,
may rely upon environmental signals within the host niche to regulate
the expression of virulence determinants. To determine if C. albicans responds to the pH of the host niche, we tested the
virulence of strains with mutations in either of two pH-regulated
genes, PHR1 and PHR2. In vitro,
PHR1 is expressed when the ambient pH is at 5.5 or higher
and deletion of the gene results in growth and morphological defects at
neutral to alkaline pHs. Conversely, PHR2 is expressed at
an ambient pH below 5.5, and the growth and morphology of the null
mutant is compromised below this pH. A PHR1 null mutant was
avirulent in a mouse model of systemic infection but uncompromised in
its ability to cause vaginal infection in rats. Since systemic pH is
near neutrality and vaginal pH is around 4.5, the virulence phenotype
paralleled the pH dependence of the in vitro phenotypes. The virulence
phenotype of a PHR2 null mutant was the inverse. The mutant
was virulent in a systemic-infection model but avirulent in a
vaginal-infection model. Heterozygous mutants exhibited partial
reductions in their pathogenic potential, suggesting a gene dosage
effect. Unexpectedly, deletion of PHR2 did not prevent
hyphal development in vaginal tissue, suggesting that it
is not essential for hyphal development in this host niche. The results
suggest that the pH of the infection site regulates the expression
of genes essential to survival within that niche. This implies that the
study of environmentally regulated genes may provide a rationale
for understanding the pathobiology of C. albicans.
 |
INTRODUCTION |
Because Candida albicans
is an important agent of opportunistic fungal infections, considerable
effort has been directed toward elucidating the biological features
that contribute to its ability to cause disease. To date, relatively
few attributes have been defined or put forth as potentially
contributing to its virulence (12). These include secretory
hydrolases, both proteinases (19) and phospholipase
(14), as well as the organism's dimorphic ability and
property of phenotypic switching (17, 21, 29, 30). A
limitation in identifying virulence attributes is the empirical
approach generally employed. Some factors have been studied because of
their significance in other pathogenic microbes or because they
represent distinctive features of the organism. A more rational
approach to elucidating the pathobiology of C. albicans
would be of substantial benefit.
Studies of bacterial pathogens have shown that many of the genes
required for virulence are regulated in response to environmental signals indigenous to the host niche (18). These signals
include temperature, pH, osmotic pressure, iron concentration, and
calcium ion concentrations (18). Recognition of this control
scheme suggests that studying an organism's response to such signals could reveal much about the mechanisms of adaptation and survival within the host niche (18). C. albicans
causes a broad range of infections in diverse host niches, and one or
more of these environmental signals may be of significance in
regulating the virulence traits of this fungus. Our prior
identification of candidal genes regulated in response to the pH of the
growth environment (20, 26) is of particular interest from
this perspective and also because pH influences the expression of some
putative virulence factors, such as the aspartyl proteinases (2,
31).
We initially identified a gene designated PHR1 which encoded
a putative cell surface glycoprotein anchored to the membrane by
glycosylphosphatidylinositol (26). This gene was expressed at high levels when the pH of the growth medium was above 5.5, but
levels were undetectable below this pH. PHR2, a functional homolog of PHR1, was subsequently identified
(20). PHR2 was expressed in an inverse pattern:
it was expressed at high levels below pH 5, but not at a pH above 6 (20). Both genes encode a function required for in vitro
morphogenesis of C. albicans. Deletion of
PHR1 results in the inability to form a normal yeast or
hyphal morphology at an alkaline pH, but not at an acidic pH, which
mirrors the expression pattern of the gene (26). Conversely, deletion of PHR2 results in a morphogenic defect which is
expressed at an acidic pH (20). In addition to the
morphogenic defect, both mutants exhibit altered growth rates at the
restrictive pH (20). More recently, we have identified a
third pH-regulated gene, PRA1, which is also involved in
morphogenesis (27).
The converse expression pattern of PHR1 and PHR2
and the pH-dependent phenotypes associated with their loss provide an
opportunity to ask whether the pH of the host niche is a relevant
environmental signal governing the virulence of C. albicans. We previously demonstrated that the virulence of
PHR1 null mutants was severely compromised in a mouse
model of systemic infection (10). This was the response predicted if pH was a relevant signal, since the phenotypic defects of
the mutant are expressed in vitro at pH values near that of mammalian
systemic pH. An untested prediction was that mutations in
PHR1 would have no consequence in an acidic host
environment. In this study we have compared the effects of mutations in
PHR1 or PHR2 on virulence in a rat vaginitis
model, which provides an acidic host niche, with their effects in a
mouse model of systemic infection, which provides a host niche with a
slightly alkaline pH. Predictions related to the virulence of these
mutants were fully substantiated. PHR1 mutants lost the
ability to cause systemic disease but were virulent in vaginal
infections. Conversely, PHR2 mutants lost the ability to
cause vaginal infection but were fully capable of causing systemic
infection. The results indicate that the pH of the host niche is a
significant environmental signal in determining the biological response
and survival of C. albicans during infection.
 |
MATERIALS AND METHODS |
Strains and growth conditions.
The C. albicans strains used and their genotypes are listed in Table
1. YPD medium (1% yeast extract, 2%
peptone, 2% dextrose) containing 150 mM HEPES was used to culture the
strains prior to inoculation into animals. The medium was adjusted to
pH 7 for the growth of strains CFM-0, CFM-2, and CFM-3. This is a
permissive pH for the growth of the PHR2 null mutant, CFM-2.
The medium was adjusted to pH 5 for the growth of strains CAS-5,
CAS-10, and CAS-11. This pH is permissive for the growth of CAS-10
containing the
phr1 mutation. The control strains SC5314
and CAI-10 were grown either at pH 7, for comparison with the
PHR2 mutants, or at pH 5, for comparison with the
PHR1 mutants. The cultures were grown to stationary phase at
28°C on a gyratory shaker at 200 rpm. Sabouraud dextrose agar (Difco)
containing chloramphenicol (50 mg/ml) was used for the enumeration of
CFU from infected kidneys and vaginal fluid. The plates were adjusted
to pH 7.0 for recovery of PHR2 mutants and to pH 4.5 for
recovery of PHR1 mutants.
Systemic infection of mice.
Stationary-phase yeast cells
were harvested from the YPD cultures by centrifugation at 1,500 × g. The cells were washed with sterile distilled water,
suspended in physiological saline solution, and counted in a
hemacytometer. Following quantitation, the cells were adjusted to a
density of 7.5 × 106/ml. The cell suspension, 0.2 ml,
containing 1.5 × 106 cells, was injected into the
lateral tail veins of inbred male CD2F1 mice (18 to 21 g; Charles
River, Calco, Italy). Each test strain was injected into 8 mice (wild
type and PHR1 mutants) or 10 mice (wild type and
PHR2 mutants), which were observed daily postinfection. The
experimental end points were the overall mortality on day 30 after
challenge (expressed as percent survival) and the median survival time
(MST), expressed in days.
Quantitation of tissue fungal burden.
The fungal burden in
the kidneys of infected mice was examined 1, 2, and 5 days
postinfection. Each candidal strain was injected intravenously into
three mice for each time point at which fungal burden was examined.
Mice were sacrificed by cervical dislocation, and the kidneys were
aseptically removed, weighed, and homogenized in 5 ml of sterile
saline. The homogenates were serially diluted and plated on Sabouraud
dextrose agar. After 48 h of incubation at 28°C, the colonies
were counted, and counts were expressed as CFU per gram of tissue.
Vaginal infection of rats.
Ovariectomized female Wistar rats
(80 to 100 g; Charles River) were maintained in pseudoestrus by
subcutaneous injection with 0.5 mg of estradiol benzoate (Benzatrone;
Samil, Rome, Italy) at 2-day intervals for the entire duration of the
experiments. Six days after the first estradiol treatment, the animals
were inoculated intravaginally with 0.1 ml of a cell suspension
containing 107 yeast cells. The cell suspension was
prepared as described for the systemic infection of mice. The inoculum
was dispensed into the vaginal cavity through a syringe equipped with a
multipurpose calibrated tip (Combitip; Pool Bioanalysis International,
Milan, Italy). Two independent experiments were carried out, and in
each experiment, each candidal strain was inoculated into five rats.
The kinetics of vaginal infection was followed by enumerating the CFU
present in the vaginal fluid. A 1-µl sample was harvested at
intervals from the vaginal cavity by using a calibrated plastic loop
(Disponoic; Pool Bioanalysis International) and was streaked onto
Sabouraud dextrose agar supplemented with chloramphenicol (50 µg/ml).
After 48 h of incubation at 28°C, the colonies were counted.
Genotypes of isolates recovered from infected animals.
The
genotypes of isolates recovered from infected tissue were examined by
Southern blot analysis. Four random isolates of each strain recovered
from vaginal samples taken 2 days following infection and five isolates
from day 9 samples were examined. For kidney samples, four or five
random isolates from samples recovered 2 or 5 days after infection were
genotyped. Genomic DNA was prepared from each isolate and characterized
by Southern blot analysis using either PHR1 or
PHR2 DNA as the hybridization probe. Genomic DNA isolation
and Southern blot analysis were performed as previously described
(20, 26).
Microscopic and histological examination of tissue samples.
Vaginal fluids were stained with periodic acid-Schiff (PAS) reagent for
microscopic examination. Mouse organs were fixed in 10% (vol/vol)
formalin, and sections of paraffin-embedded tissues were examined after
treatment with PAS and Van Gieson stains. Details of these procedures
have been given elsewhere (2, 5).
Statistical analysis.
Statistical comparisons were performed
by the Mann-Whitney U test for comparisons of MST and by Fisher's
exact test for comparisons of end point mortality. For the differences
in vaginal CFU, the Mann-Whitney U test and Student's t
test were used.
 |
RESULTS |
PHR2 is not required for systemic infection of
mice.
The blood pH of mice is approximately 7.3. When
C. albicans is grown at this pH in vitro,
PHR1 is expressed at high levels and expression of
PHR2 is undetectable (20, 26). Accordingly, PHR1 null mutants exhibit growth and morphological defects
at alkaline pHs, while PHR2 null mutants are phenotypically
normal at these pHs. Hence, in contrast to the dramatic effect of
PHR1 mutations (10), loss of PHR2 was
expected to have little or no effect on the ability of the mutant
strain to establish systemic infection. This hypothesis was tested by
intravenous infection of CD2F1 mice with the various mutants.
As a control, we first established that CD2F1 mice yielded results
similar to those previously obtained with BALB/c mice (10). Intravenous injection of 1.5 × 106 cells of the
clinical isolate SC5314 resulted in 100% mortality within 3 days after
challenge (Fig. 1a). Identical results
were obtained with strain CAI-10, which is a heterozygous
Urd+ derivative of strain CAF-3, the parental strain of all
the PHR mutants (20, 26) (data not shown). There was a
dramatic difference between animals injected with the wild-type strain,
SC5314 (100% mortality), and those challenged with the PHR1
null mutant (0% mortality) (Fig. 1a). This confirmed previous results
demonstrating the avirulence of this mutant (10).
Interestingly, the two mutants that were heterozygous for
PHR1, the parental strain CAS-5 and the revertant strain
CAS-11, produced similar survival curves, but the extent of mortality
was half that of the wild-type strain (Fig. 1a), suggesting that a
single allele is insufficient for full expression of the pathogenic
potential of these strains. All of these differences, as well as the
differences in MST, between any two groups of animals were
statistically significant (P < 0.05 or
P < 0.01 with the two-tailed test, depending on the
specific comparison). An independent repetition of the experiment
yielded essentially the same results.

View larger version (10K):
[in this window]
[in a new window]
|
FIG. 1.
Survival of CD2F1 mice following intravenous challenge
with C. albicans. Results from independent experiments
comparing the wild-type strain SC5314 with PHR1 mutants and
PHR2 mutants are shown. The results shown in each panel are
from one of two independent experiments.
|
|
The requirement for PHR2 was tested by infection with strain
CFM-2, which contains a homozygous deletion of this gene. Infection with this mutant yielded results comparable to those for the wild-type strain, 100% mortality within 4 days (Fig. 1b). Infection with the
heterozygous parent strain, CFM-0, or the heterozygous revertant of
CFM-2, strain CFM-3, also resulted in 100 and 80% mortality, respectively, within the 1st week (Fig. 1b). There were no
statistically significant differences in the end point mortality.
Similar results were obtained in a second independent repetition of the
experiment. Small (1- to 2-day) differences were observed between the
MST of the mice inoculated with the null mutant or the revertant and that of the animals injected with SC5314, but these differences either
were statistically insignificant or were not observed in the
independent repetition of the experiment.
The mortality results were mirrored in the kidney fungal burdens of
infected mice. The fungal burdens in animals infected with SC5314 and
in animals infected with any of the PHR2 mutants were
comparable (Table 2). In contrast,
infection with the PHR1 mutants resulted in substantially
lower (>1 log unit) counts (Table 2). Histological sections of kidneys
from infected mice showed that the PHR2 mutants exhibited
normal hyphal development in this tissue (Fig.
2), further demonstrating the negligible
consequences of these mutations at the systemic pH.

View larger version (118K):
[in this window]
[in a new window]
|
FIG. 2.
PAS-Van Gieson-stained sections of kidneys of CD2F1 mice
5 days after challenge with strain CFM-0 (A), CFM-2 (B), or CFM-3 (C).
Arrows indicate locations of hyphal forms. Extensive hyphal invasion of
the organ was observed in all sections. Magnification, ×315.
|
|
As a control, the genotypes at the mutant loci of isolates recovered
from the kidneys were examined by Southern blot analysis. In all cases,
the genotypes of the recovered strains were identical to those of cells
in the initial inoculum (data not shown). Thus, by all criteria
examined, the loss of PHR2 had a minimal effect, if any, on
the ability of the strain to establish systemic infection, whereas the
loss of PHR1 had a marked influence, as previously established (10) and confirmed here.
PHR2, but not PHR1, is required for rat
vaginitis.
Rat vaginal pH is approximately 4.5; thus, the rat
vagina provides a host niche with a pH significantly different from
that of blood. Thus, the requirement for PHR1 and
PHR2 in vaginal infections was predicted to be the opposite
of that demonstrated for systemic infection. This prediction was tested
in two independent experiments with identical results. The results of
one of these experiments are shown in Fig.
3.

View larger version (18K):
[in this window]
[in a new window]
|
FIG. 3.
C. albicans count during vaginal
infection of ovariectomized, pseudoestrus rats. The animals were
inoculated on day 0 with the wild-type control, SC5314, or the
indicated PHR1 mutant (a) or with the wild-type strain or
the indicated PHR2 mutant (b). Error bars, standard errors
of the means.
|
|
Inoculation with the wild-type strain SC5314 resulted in a sustained
vaginal infection during the 1st week, with a gradual decline in the
fungal burden over the ensuing 3 weeks (Fig. 3a). The kinetics of
clearance with this strain was very similar to that reported for other
vaginopathic strains (4, 5). As predicted, loss of either
one or both alleles of PHR1 was without effect; infection
with either the null mutant or the heterozygous control strains
resulted in rates of clearance identical to that for the wild-type
strain (Fig. 3a). The control strain CAI-10 gave similar results
(data not shown). No statistically significant differences were
detected with the Mann-Whitney U test or Student's t test
between any two groups of rats, at any time point during infection.
Microscopic examination of vaginal scrapings taken from rats infected
with strain CAS-5, CAS-10, or CAS-11 showed the typical yeast forms
1 h after challenge (Fig. 4), but 2 days after challenge, each of these strains developed hyphal filaments
which persisted until at least day 7 (Fig. 4). Identical morphologies
were observed with either SC5314 or CAI-10 (data not shown). Thus, the
morphological aberrations characteristic of the PHR1 null
mutant when it is grown at an alkaline pH were not evident. Multiple
isolates recovered from these infected animals were genotyped and found
to contain the expected mutation(s) at the PHR1 locus,
verifying that the infections were due to propagation of the mutants.
Together, these data demonstrated that PHR1 is not required
for vaginal infection or proper morphogenesis in an acidic host niche.

View larger version (146K):
[in this window]
[in a new window]
|
FIG. 4.
Photomicrographs of vaginal scrapings. (A through C)
Samples of strains CAS-5, CAS-10, and CAS-11, respectively, taken
1 h postinfection. (D through F) Samples of strains CAS-5, CAS-10,
and CAS-11, respectively, taken 2 days postinfection. The vaginal
smears were stained by the PAS-Van Gieson method. Note the
qualitatively similar hyphal development of all strains after 2 days of
infection. Magnification, ×192.
|
|
In contrast to the PHR1 mutants, deletion of PHR2
had a dramatic effect on the kinetics of vaginal clearing. Within
24 h of infection, the fungal burden with the PHR2 null
mutant, CFM-2, was reduced to half that with the clinical isolate,
SC5314 (Fig. 3b). This rapid rate of clearance continued over the next
6 days. The fungal burden at day 7 was lower than that seen 4 weeks
after infection with the wild-type strain, SC5314. Infection with
either of the heterozygous control strains, CFM-0 or CFM-3, resulted in
much higher fungal burdens and a more prolonged course of infection than infection with the null mutant. Nonetheless, these strains reproducibly showed slightly, but statistically significantly, lower
fungal burdens and slightly more rapid clearance than those observed
with homozygous Phr2+ strains. There were highly
significant differences (P < 0.01 with the two-tailed
Mann-Whitney U test) at all time points between the fungal burdens of
rats challenged with SC5314, CFM-0, or CFM-3 and those of rats
receiving the null mutant, CFM-2. Statistically significant differences
(P < 0.01 with the two-tailed Mann-Whitney U test)
were also noted between the fungal burdens of rats challenged with
SC5314 and those of rats challenged with either heterozygous strain,
CFM-0 or CFM-3, during the 1st week of infection. No statistically significant difference, at any time point, was observed between the two
heterozygous strains. Thus, there was a clear requirement for
PHR2 in establishing and maintaining vaginal infection, and the loss of even one allele had a demonstrable effect.
Microscopic examination of vaginal scrapings taken from the rats
infected with the PHR2 mutants was performed to
determine if the in vitro morphological aberrations
characteristic of the null mutant were evident in vivo. The
heterozygous mutants CFM-0 and CFM-3 showed the expected cell
morphologies. One hour after inoculation the cells had a yeast
morphology, and extensive hyphal growth was evident 2 days
postinfection (Fig. 5). However,
unexpected results were observed with samples from rats infected with
the null mutant. Whereas a PHR2 null mutation results in an
aberrant cell morphology at an acidic pH in vitro (20),
apparently normal hyphae were present in the vaginal samples (Fig. 5).
This was not due to a contaminant strain, since Southern blot analysis of isolates recovered from these rats demonstrated the presence of the
PHR2 deletion (data not shown). Thus, while PHR2
is required for vaginal infection, ostensibly this requirement is not
related to hyphal development.

View larger version (127K):
[in this window]
[in a new window]
|
FIG. 5.
Photomicrographs of vaginal scrapings. (A through C)
Samples of strains CFM-0, CFM-2, and CFM-3, respectively, taken 1 h postinfection. (D through F) Samples of strains CFM-0, CFM-2, and
CFM-3, respectively, taken 2 days postinfection. The vaginal smears
were stained by the PAS-Van Gieson method. Note the qualitatively
similar hyphal development of all three strains. Magnification,
×192.
|
|
 |
DISCUSSION |
The question posed in this study was whether or not the pH of the
host niche acts as an environmental signal that regulates gene
expression in and virulence of Candida albicans. This
question was addressed by using mutants that exhibit pH-dependent
phenotypes as biological probes. There were two pertinent observations
in this regard. One was that a PHR1 null mutant was
avirulent when tested in a mouse model of systemic candidiasis but was
indistinguishable from a wild-type strain in its ability to cause
vaginal disease. The other was that a PHR2 null mutant was
inversely affected. It was avirulent in a rat model of vaginal
candidiasis but uncompromised in its ability to cause systemic
infection in mice. Several controls were incorporated into these
studies to verify that these phenotypes were direct consequences of the
mutations in PHR1 and PHR2. Reintroduction of a
wild-type allele into the respective mutant reverted the phenotype to
that of the parental heterozygote, demonstrating the correspondence
between genotype and phenotype. In addition, the genotypes of isolates
recovered from infected animals were determined to demonstrate that
the infections resulted from the inoculum of mutant cells and not
from endogenous wild-type strains or cross-contamination from
other animals.
The key concept in interpreting these results is that PHR1
and PHR2 encode structurally homologous proteins that are
functionally interchangeable (20). Forced expression of
PHR1 at an acidic pH restores normal growth and
morphogenesis to a PHR2 null mutant, and conversely, forced
expression of PHR2 at an alkaline pH complements a deletion
of PHR1 (20). Thus, a PHR1 null mutant
grown at an alkaline pH has essentially the same biochemical defect as
a PHR2 null mutant grown at an acidic pH. Recognizing this
equivalence of function, the avirulence of the PHR1 null
mutant in systemic infection implies that PHR2 is not
expressed at all or is not expressed to a significant extent under
these conditions. If it were, it would complement the deletion of
PHR1, and the cells would be phenotypically normal. By the
same reasoning, PHR1 is not expressed during vaginal
infection; if it were, it would complement the PHR2 deletion
and the cells would exhibit normal virulence. One caveat to this
interpretation is the possibility that, in addition to their shared
activity, either Phr1p or Phr2p has an additional function, not shared
by the other, that specifically affects virulence. While we cannot
exclude this possibility, there is certainly no evidence for it. Thus,
we conclude that these genes are differentially expressed in vivo,
PHR1 is expressed during systemic infection but not during
vaginal infection, and PHR2 has the inverse pattern of
expression.
What factor(s) governs the differential expression of these genes in
vivo? Previous work established that expression of PHR1 and
PHR2 in vitro is regulated in response to the ambient pH of the growth environment, independent of temperature, nutritional factors, or morphology (20, 26). The in vivo expression
patterns exhibited a similar correlation with pH. The systemic pH of
mice is 7.3, while the vaginal cavity in rats has a pH of 4.5. Thus, PHR1 was expressed at a near-neutral pH in the systemic
niche but not at pH 4.5 in the vaginal niche. In vitro, the same pH dependence is observed; PHR1 expression occurs only when the
ambient pH is 5.5 or higher (26). Conversely,
PHR2 was expressed in the acidic environment of the vaginal
niche but not in the slightly alkaline environment of the blood. This
parallels the in vitro pH-dependent pattern in which PHR2 is
expressed at a pH of 5.0 or lower (20). Therefore, the
simplest interpretation of the in vivo expression pattern is that the
pH-dependent regulation demonstrated in vitro is operative within the
host niche. However, we cannot exclude the possibility that factors
other than pH influence the expression of these genes. There are
numerous differences between the two animal models. They differed in
species, sex of the animals, and pharmacological treatment with
estrogen. Even if these differences are eliminated, the systemic and
vaginal environments are grossly different. However, there is no reason to believe that the pH-dependent regulation seen in vitro would become
inoperative in vivo, and no regulatory influences other than pH need be
hypothesized to explain the results.
While the results clearly demonstrated the requirement of
PHR1 and PHR2 for systemic and vaginal
infections, respectively, we can only speculate as to why the null
mutants are avirulent. Given the common biochemical defect of the
mutants, avirulence in the systemic and vaginal models may likely have
similar bases. The precise biochemical function of the encoded proteins
has not been defined. In Saccharomyces cerevisiae, deletion
of the PHR1/PHR2 homolog GAS1/GGP1 CWH52 results
in multiple phenotypic consequences, including alterations in the
structure of the cell wall (15, 23-25). Although differing
from S. cerevisiae, PHR1 and PHR2
exhibit similar pH-dependent defects in cell wall organization
(8). It is not clear if these are direct or indirect
consequences of the mutations or whether they directly impact
virulence. However, one secondary consequence which is likely to have a
significant impact on virulence is the severely compromised growth
rates of the mutants. The doubling time of a strain lacking both
PHR1 and PHR2 is five times that of a wild-type
strain (20). At a systemic pH the PHR1 null
mutant is phenotypically Phr1
Phr2
, since
PHR2 is not expressed at this pH. Similarly, the
PHR2 null mutant in the acidic environment of the vagina is
the phenotypic equivalent of the double mutant, since PHR1
is not expressed. Thus, the in vivo growth of these null mutants should
be greatly reduced relative to that of a wild-type strain. This gross
reduction in growth rate may be incompatible with the establishment or
maintenance of infection in either host niche. Alternatively, or in
addition, the mutations may indirectly affect the expression of
virulence-specific attributes. For instance, the secretory aspartyl
proteinases (SAPs) have been implicated in the vaginopathic potential
of C. albicans and Candida parapsilosis
(5, 7). Of the multiple SAP genes in C. albicans (19), SAP2 is known to require
acidic pH for expression and is expressed during vaginal infection
(7). Moreover, recent genetic analysis has shown this gene
to be essential for such infections (6). The cell surface
defects in the PHR2 mutant may indirectly compromise
SAP2 expression, leading to reduced virulence. A less likely
explanation is that PHR1 and PHR2 encode multifunctional proteins and that, in addition to their common activity, Phr1p has a secondary function specific to systemic virulence
and Phr2p has a secondary activity specific to vaginal infection. If
the avirulence is due simply to the altered growth rate, then the
virulence patterns of the mutants can be predicted for any animal model
based on the pH of the host niche. In this regard it should be noted
that a PHR2 null mutant, unlike a PHR1 null
mutant, is defective in gastric colonization of mice, as would be
predicted based on pH alone (6).
In addition to the differential avirulence of PHR1 and
PHR2 mutants, there were several other interesting
observations. One was an apparent gene dosage effect. Both
mutants that were heterozygous for a deletion of PHR1, the
parent and the revertant of the null strain, caused only 50% of the
mortality associated with the homozygous Phr1+ strains,
SC5314 and CAI-10. Similarly, heterozygous PHR2 mutants showed a reproducible reduction in vaginal virulence, although it was
not as dramatic. While these mutants are also heterozygous for
URA3 by virtue of the construction methods, and while
URA3 is required for virulence (16, 28), this
does not account for the observed attenuation, since the control
strain, CAI-10, is also heterozygous for URA3 and exhibited
full virulence in both animal models. Genetic instability of the
URA3 marker also seems an unlikely explanation. Although
URA3 is flanked by direct repeats in these strains and this
can cause recombinational loss of the marker (9), any
virulence effects of this instability would be manifested equally
in all strains, and this was not observed. We cannot discount the
possibility that secondary mutations were inadvertently introduced
during construction of the strains and that these resulted in the
attenuation of the heterozygous strains. However, if this did occur, it
had to have occurred independently in the PHR1 and
PHR2 mutant lines. This follows from the observation that
the virulence of the parental strain of both mutant lineages was
indistinguishable from that of a wild-type strain. It might also be
noted that the PHR1 revertant, strain CAS-11, showed no attenuation when systemic infection was tested in BALB/c mice (10), suggesting that these apparent dosage effects may not be evident in all host strains.
An unexpected observation was that histological examination of vaginal
tissue demonstrated the presence of morphologically normal hyphae in
animals infected with the PHR2 null mutant. This would seem
to contradict the foregoing arguments that PHR1 was not
expressed in this niche. However, these hyphal forms were exceedingly
few in number and not characteristic of the vast majority of the cells.
Their presence might indicate limited microenvironments within the
vaginal tissue with a pH commensurate with PHR1 expression and, thus, with limited hypha formation. We also cannot rule out the
possibility that these represent a few endogenous or exogenous wild-type cells. Although the genotypes of a number of isolates recovered from these infections were determined, the screening was not
extensive enough to detect infrequent members of the population.
The primary conclusion from these studies is that pH appears to be an
environmental signal governing differential gene expression and
virulence. A corollary of this conclusion is that the ability of
C. albicans to inhabit diverse host niches is mediated
by adaptations specific to the niche and that these adaptations are
effected, at least in part, by differential gene expression. This was
already implicit in previous work with C. albicans
CA-2, an echinocandin-resistant mutant (4). This strain was
unable to form germ tubes in vitro and was avirulent in systemic
infection models, yet it was competent in establishing vaginal
infections and developing a hyphal morphology in this host niche
(4). However, the nature of the mutation(s) in this strain
is not defined, and in view of the chemical mutagenesis used, it is
likely that multiple mutations were introduced. In contrast, this study
used well-defined mutants, and the expression patterns of the mutated
genes had been previously established.
A broader implication of these results is that environmental cues in
the host niche may be of similar significance to fungal pathogens as to
bacterial pathogens, serving to regulate expression of the genetic
potential needed to survive within that niche. The response to pH is
not likely to be limited to these two genes, since in vitro expression
of other candidal genes is modulated by ambient pH (27, 31).
It is also unlikely that pH is the only environmental signal relevant
to candidal infection. Temperature is another parameter with
significant effects on candidal biology, affecting dimorphism
(22), surface properties (13), virulence (1), and gene expression (3). This suggests a new
avenue and rationale to dissecting the biological basis of candidal
virulence. By analyzing the organism's response to environmental
signals intrinsic to the host niche, we may learn much about the basis of its pathobiology.
 |
ACKNOWLEDGMENTS |
F. De Bernardis and A. Cassone were supported by a grant from the
National AIDS Project of Italy, contract no. 940/U. W. A. Fonzi was supported by Public Health Service grant GM47727 from the
National Institutes of Health and the Burroughs Wellcome Fund Scholar
Award in Molecular Pathogenic Mycology. F.A.M. was supported by a
postdoctoral fellowship from the German Science Foundation.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Microbiology and Immunology, Georgetown University, 3900 Reservoir Rd. N.W., Washington, DC 20007-2197. Phone: (202) 687-1135. Fax: (202) 687-1800. E-mail: fonziw{at}medlib.georgetown.edu.
Editor: T. R. Kozel
 |
REFERENCES |
| 1.
|
Antley, P. P., and K. C. Hazen.
1988.
Role of yeast cell growth temperature on [sic] Candida albicans virulence in mice.
Infect. Immun.
56:2884-2890[Abstract/Free Full Text].
|
| 2.
|
Cassone, A.,
F. De Bernardis,
F. Mondello,
T. Ceddia, and L. Agatensi.
1987.
Evidence for a correlation between proteinase secretion and vulvovaginal candidosis.
J. Infect. Dis.
156:777-783[Medline].
|
| 3.
|
Chen, J.-Y., and W. A. Fonzi.
1992.
A temperature-regulated, retrotransposon-like element from Candida albicans.
J. Bacteriol.
174:5624-5632[Abstract/Free Full Text].
|
| 4.
|
De Bernardis, F.,
D. Adriani,
R. Lorenzini,
E. Pontieri,
G. Carruba, and A. Cassone.
1993.
Filamentous growth and elevated vaginopathic potential of a nongerminative variant of Candida albicans expressing low virulence in systemic infection.
Infect. Immun.
61:1500-1508[Abstract/Free Full Text].
|
| 5.
|
De Bernardis, F.,
L. Agatensi,
Y. K. Ross,
G. W. Emerson,
R. A. Lorenzini,
P. A. Sullivan, and A. Cassone.
1990.
Evidence for a role for secreted aspartate proteinase of Candida albicans in vulvovaginal candidiasis.
J. Infect. Dis.
161:1276-1283[Medline].
|
| 6.
| De Bernardis, F., et al. 1998. Unpublished data.
|
| 7.
|
De Bernardis, F.,
A. Cassone,
J. Sturtevant, and R. Calderone.
1995.
Expression of Candida albicans SAP1 and SAP2 in experimental vaginitis.
Infect. Immun.
63:1887-1892[Abstract].
|
| 8.
| Fonzi, W. A. Unpublished data.
|
| 9.
|
Fonzi, W. A., and M. Y. Irwin.
1993.
Isogenic strain construction and gene mapping in Candida albicans.
Genetics
134:717-728[Abstract].
|
| 10.
|
Ghannoum, M. A.,
B. Spellberg,
S. M. Saporito-Irwin, and W. A. Fonzi.
1995.
Reduced virulence of Candida albicans PHR1 mutants.
Infect. Immun.
63:4528-4530[Abstract].
|
| 11.
|
Gillum, A. M.,
E. Y. H. Tsay, and D. R. Kirsch.
1984.
Isolation of the Candida albicans gene for orotidine-5'-phosphate decarboxylase by complementation of S. cerevisiae ura3 and E. coli pyrF mutations.
Mol. Gen. Genet.
198:179-182[Medline].
|
| 12.
|
Hazen, K. C.,
D. L. Brawner,
M. H. Riesselman,
M. A. Jutila, and J. E. Cutler.
1991.
Differential adherence of hydrophobic and hydrophilic Candida albicans yeast cells to mouse tissue.
Infect. Immun.
59:907-912[Abstract/Free Full Text].
|
| 13.
|
Hazen, K. C., and B. W. Hazen.
1987.
Temperature-modulated physiological characteristics of Candida albicans.
Microbiol. Immunol.
31:497-508[Medline].
|
| 14.
|
Ibrahim, A. S.,
F. Mirbod,
S. G. Filler,
Y. Banno,
G. T. Cole,
Y. Kitajima,
J. E. Edwards, Jr.,
Y. Nozawa, and M. A. Ghannoum.
1995.
Evidence implicating phospholipase as a virulence factor of Candida albicans.
Infect. Immun.
63:1993-1998[Abstract].
|
| 15.
|
Kapteyn, J. C.,
A. F. J. Ram,
E. M. Groos,
R. Kollar,
R. C. Montijn,
H. van den Ende,
A. Llobell, and F. M. Klis.
1997.
Altered extent of cross-linking of 1,6-glucosylated mannoproteins to chitin in Saccharomyces cerevisiae mutants with reduced cell wall 1,3-glucan content.
J. Bacteriol.
179:6279-6284[Abstract/Free Full Text].
|
| 16.
|
Kirsch, D. R., and R. R. Whitney.
1991.
Pathogenicity of Candida albicans auxotrophic mutants in experimental infections.
Infect. Immun.
59:3297-3300[Abstract/Free Full Text].
|
| 17.
|
Lo, H.,
J. R. Köhler,
B. DiDomenico,
D. Loebenberg,
A. Cacciapuoti, and G. R. Fink.
1997.
Nonfilamentous C. albicans mutants are avirulent.
Cell
90:939-949[Medline].
|
| 18.
|
Mekalanos, J. J.
1992.
Environmental signals controlling expression of virulence determinants in bacteria.
J. Bacteriol.
174:1-7[Free Full Text].
|
| 19.
|
Monod, M.,
G. Togni,
B. Hube, and D. Sanglard.
1994.
Multiplicity of genes encoding secreted aspartic proteinases in Candida species.
Mol. Microbiol.
13:357-368[Medline].
|
| 20.
|
Mühlschlegel, F. A., and W. A. Fonzi.
1997.
PHR2 of Candida albicans encodes a functional homolog of the pH-regulated gene PHR1 with an inverted pattern of expression.
Mol. Cell. Biol.
17:5960-5967[Abstract].
|
| 21.
|
Odds, F. C.
1987.
Candida infections: an overview.
Crit. Rev. Microbiol.
15:1-5[Medline].
|
| 22.
|
Odds, F. C.
1988.
Candida and candidosis. A review and bibliography, 2nd ed.
Bailliere-Tindall, London, United Kingdom.
|
| 23.
|
Popolo, L.,
D. Gilardelli,
P. Bonfante, and M. Vai.
1997.
Increase in chitin as an essential response to defects in assembly of cell wall polymers in the ggp11 mutant of Saccharomyces cerevisiae.
J. Bacteriol.
179:463-469[Abstract/Free Full Text].
|
| 24.
|
Popolo, L.,
M. Vai,
E. Gatti,
S. Porello,
P. Bonfante,
R. Balestrini, and L. Alberghina.
1993.
Physiological analysis of mutants indicates involvement of the Saccharomyces cerevisiae GPI-anchored protein gp115 in morphogenesis and cell separation.
J. Bacteriol.
175:1879-1885[Abstract/Free Full Text].
|
| 25.
|
Ram, A. F. J.,
J. C. Kapteyn,
R. C. Montijn,
L. H. P. Caro,
J. E. Douwes,
W. Baginsky,
P. Mazur,
H. van den Ende, and F. M. Klis.
1998.
Loss of the plasma membrane-bound protein Gas1p in Saccharomyces cerevisiae results in the release of 1,3-glucan into the medium and induces a compensation mechanism to ensure cell wall integrity.
J. Bacteriol.
180:1418-1424[Abstract/Free Full Text].
|
| 26.
|
Saporito-Irwin, S. M.,
C. E. Birse,
P. S. Sypherd, and W. A. Fonzi.
1995.
PHR1, a pH-regulated gene of Candida albicans, is required for morphogenesis.
Mol. Cell. Biol.
15:601-613[Abstract].
|
| 27.
|
Sentandreu, M.,
M. V. Elorza,
R. Sentandreu, and W. A. Fonzi.
1998.
Cloning and characterization of PRA1, a gene encoding a novel pH-regulated antigen of Candida albicans.
J. Bacteriol.
180:282-289[Abstract/Free Full Text].
|
| 28.
|
Shepherd, M. G.
1985.
Pathogenicity of morphological and auxotrophic mutants of Candida albicans in experimental infections.
Infect. Immun.
50:541-544[Abstract/Free Full Text].
|
| 29.
|
Slutsky, B.,
J. Buffo, and D. R. Soll.
1985.
High-frequency switching of colony morphology in Candida albicans.
Science
230:666-669[Abstract/Free Full Text].
|
| 30.
|
Slutsky, B.,
M. Staebell,
J. Anderson,
L. Risen,
M. Pfaller, and D. R. Soll.
1987.
"White-opaque transition": a second high-frequency switching system in Candida albicans.
J. Bacteriol.
169:189-197[Abstract/Free Full Text].
|
| 31.
|
White, T. C., and N. Agabian.
1995.
Candida albicans secreted aspartyl proteinases: isoenzyme pattern is determined by cell type, and levels are determined by environmental factors.
J. Bacteriol.
177:5215-5221[Abstract/Free Full Text].
|
Infect Immun, July 1998, p. 3317-3325, Vol. 66, No. 7
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Chaffin, W. L.
(2008). Candida albicans Cell Wall Proteins. Microbiol. Mol. Biol. Rev.
72: 495-544
[Abstract]
[Full Text]
-
Popolo, L., Ragni, E., Carotti, C., Palomares, O., Aardema, R., Back, J. W., Dekker, H. L., de Koning, L. J., de Jong, L., de Koster, C. G.
(2008). Disulfide Bond Structure and Domain Organization of Yeast {beta}(1,3)-Glucanosyltransferases Involved in Cell Wall Biogenesis. J. Biol. Chem.
283: 18553-18565
[Abstract]
[Full Text]
-
Sosinska, G. J., de Groot, P. W. J., Teixeira de Mattos, M. J., Dekker, H. L., de Koster, C. G., Hellingwerf, K. J., Klis, F. M.
(2008). Hypoxic conditions and iron restriction affect the cell-wall proteome of Candida albicans grown under vagina-simulative conditions. Microbiology
154: 510-520
[Abstract]
[Full Text]
-
Sagaram, U. S., Shaw, B. D., Shim, W.-B.
(2007). Fusarium verticillioides GAP1, a gene encoding a putative glycolipid-anchored surface protein, participates in conidiation and cell wall structure but not virulence. Microbiology
153: 2850-2861
[Abstract]
[Full Text]
-
Biswas, S., Van Dijck, P., Datta, A.
(2007). Environmental Sensing and Signal Transduction Pathways Regulating Morphopathogenic Determinants of Candida albicans. Microbiol. Mol. Biol. Rev.
71: 348-376
[Abstract]
[Full Text]
-
Li, L., Redding, S., Dongari-Bagtzoglou, A.
(2007). Candida glabrata, an Emerging Oral Opportunistic Pathogen. J. Dent. Res.
86: 204-215
[Abstract]
[Full Text]
-
Soloviev, D. A., Fonzi, W. A., Sentandreu, R., Pluskota, E., Forsyth, C. B., Yadav, S., Plow, E. F.
(2007). Identification of pH-Regulated Antigen 1 Released from Candida albicans as the Major Ligand for Leukocyte Integrin {alpha}Mbeta2. J. Immunol.
178: 2038-2046
[Abstract]
[Full Text]
-
Mitchell, B. M., Wu, T. G., Jackson, B. E., Wilhelmus, K. R.
(2007). Candida albicans Strain-Dependent Virulence and Rim13p-Mediated Filamentation in Experimental Keratomycosis. IOVS
48: 774-780
[Abstract]
[Full Text]
-
Richard, M. L., Plaine, A.
(2007). Comprehensive Analysis of Glycosylphosphatidylinositol-Anchored Proteins in Candida albicans. Eukaryot Cell
6: 119-133
[Full Text]
-
Cornet, M., Bidard, F., Schwarz, P., Da Costa, G., Blanchin-Roland, S., Dromer, F., Gaillardin, C.
(2005). Deletions of Endocytic Components VPS28 and VPS32 Affect Growth at Alkaline pH and Virulence through both RIM101-Dependent and RIM101-Independent Pathways in Candida albicans. Infect. Immun.
73: 7977-7987
[Abstract]
[Full Text]
-
Badrane, H., Cheng, S., Nguyen, M. H., Jia, H. Y., Zhang, Z., Weisner, N., Clancy, C. J.
(2005). Candida albicans IRS4 contributes to hyphal formation and virulence after the initial stages of disseminated candidiasis. Microbiology
151: 2923-2931
[Abstract]
[Full Text]
-
Taylor, B. N., Staib, P., Binder, A., Biesemeier, A., Sehnal, M., Rollinghoff, M., Morschhauser, J., Schroppel, K.
(2005). Profile of Candida albicans-Secreted Aspartic Proteinase Elicited during Vaginal Infection. Infect. Immun.
73: 1828-1835
[Abstract]
[Full Text]
-
Gorodeski, G. I., Hopfer, U., Liu, C. C., Margles, E.
(2005). Estrogen Acidifies Vaginal pH by Up-Regulation of Proton Secretion via the Apical Membrane of Vaginal-Ectocervical Epithelial Cells. Endocrinology
146: 816-824
[Abstract]
[Full Text]
-
de Repentigny, L., Lewandowski, D., Jolicoeur, P.
(2004). Immunopathogenesis of Oropharyngeal Candidiasis in Human Immunodeficiency Virus Infection. Clin. Microbiol. Rev.
17: 729-759
[Abstract]
[Full Text]
-
Martinez-Lopez, R., Monteoliva, L., Diez-Orejas, R., Nombela, C., Gil, C.
(2004). The GPI-anchored protein CaEcm33p is required for cell wall integrity, morphogenesis and virulence in Candida albicans. Microbiology
150: 3341-3354
[Abstract]
[Full Text]
-
Kottom, T. J., Limper, A. H.
(2004). Pneumocystis carinii Cell Wall Biosynthesis Kinase Gene CBK1 Is an Environmentally Responsive Gene That Complements Cell Wall Defects of cbk-Deficient Yeast. Infect. Immun.
72: 4628-4636
[Abstract]
[Full Text]
-
Galan, A., Casanova, M., Murgui, A., MacCallum, D. M., Odds, F. C., Gow, N. A. R., Martinez, J. P.
(2004). The Candida albicans pH-regulated KER1 gene encodes a lysine/glutamic-acid-rich plasma-membrane protein that is involved in cell aggregation. Microbiology
150: 2641-2651
[Abstract]
[Full Text]
-
Brand, A., MacCallum, D. M., Brown, A. J. P., Gow, N. A. R., Odds, F. C.
(2004). Ectopic Expression of URA3 Can Influence the Virulence Phenotypes and Proteome of Candida albicans but Can Be Overcome by Targeted Reintegration of URA3 at the RPS10 Locus. Eukaryot Cell
3: 900-909
[Abstract]
[Full Text]
-
Li, M., Martin, S. J., Bruno, V. M., Mitchell, A. P., Davis, D. A.
(2004). Candida albicans Rim13p, a Protease Required for Rim101p Processing at Acidic and Alkaline pHs. Eukaryot Cell
3: 741-751
[Abstract]
[Full Text]
-
Lotz, H., Sohn, K., Brunner, H., Muhlschlegel, F. A., Rupp, S.
(2004). RBR1, a Novel pH-Regulated Cell Wall Gene of Candida albicans, Is Repressed by RIM101 and Activated by NRG1. Eukaryot Cell
3: 776-784
[Abstract]
[Full Text]
-
Monteagudo, C, Viudes, A, Lazzell, A, Martinez, J P, Lopez-Ribot, J L
(2004). Tissue invasiveness and non-acidic pH in human candidiasis correlate with "in vivo" expression by Candida albicans of the carbohydrate epitope recognised by new monoclonal antibody 1H4. J. Clin. Pathol.
57: 598-603
[Abstract]
[Full Text]
-
Mukherjee, P. K., Chandra, J., Kuhn, D. M., Ghannoum, M. A.
(2003). Differential expression of Candida albicans phospholipase B (PLB1) under various environmental and physiological conditions. Microbiology
149: 261-267
[Abstract]
[Full Text]
-
Sanchez-Martinez, C., Perez-Martin, J.
(2002). Gpa2, a G-Protein {alpha} Subunit Required for Hyphal Development in Candida albicans. Eukaryot Cell
1: 865-874
[Abstract]
[Full Text]
-
Chen, Y.-C., Wu, C.-C., Chung, W.-L., Lee, F.-J. S.
(2002). Differential secretion of Sap4-6 proteins in Candida albicans during hyphae formation. Microbiology
148: 3743-3754
[Abstract]
[Full Text]
-
Santoni, G., Boccanera, M., Adriani, D., Lucciarini, R., Amantini, C., Morrone, S., Cassone, A., De Bernardis, F.
(2002). Immune Cell-Mediated Protection against Vaginal Candidiasis: Evidence for a Major Role of Vaginal CD4+ T Cells and Possible Participation of Other Local Lymphocyte Effectors. Infect. Immun.
70: 4791-4797
[Abstract]
[Full Text]
-
Heymann, P., Gerads, M., Schaller, M., Dromer, F., Winkelmann, G., Ernst, J. F.
(2002). The Siderophore Iron Transporter of Candida albicans (Sit1p/Arn1p) Mediates Uptake of Ferrichrome-Type Siderophores and Is Required for Epithelial Invasion. Infect. Immun.
70: 5246-5255
[Abstract]
[Full Text]
-
Penalva, M. A., Arst, H. N. Jr.
(2002). Regulation of Gene Expression by Ambient pH in Filamentous Fungi and Yeasts. Microbiol. Mol. Biol. Rev.
66: 426-446
[Abstract]
[Full Text]
-
Knight, S. A. B., Lesuisse, E., Stearman, R., Klausner, R. D., Dancis, A.
(2002). Reductive iron uptake by Candida albicans: role of copper, iron and the TUP1 regulator. Microbiology
148: 29-40
[Abstract]
[Full Text]
-
Kottom, T. J., Thomas, C. F. Jr., Limper, A. H.
(2001). Characterization of Pneumocystis carinii PHR1, a pH-Regulated Gene Important for Cell Wall Integrity. J. Bacteriol.
183: 6740-6745
[Abstract]
[Full Text]
-
Weig, M., Haynes, K., Rogers, T. R., Kurzai, O., Frosch, M., Muhlschlegel, F. A.
(2001). A GAS-like gene family in the pathogenic fungus Candida glabrata. Microbiology
147: 2007-2019
[Abstract]
[Full Text]
-
Mingot, J. M., Espeso, E. A., Díez, E., Peñalva, M. A.
(2001). Ambient pH Signaling Regulates Nuclear Localization of the Aspergillus nidulans PacC Transcription Factor. Mol. Cell. Biol.
21: 1688-1699
[Abstract]
[Full Text]
-
Poussereau, N., Creton, S., Billon-Grand, G., Rascle, C., Fevre, M.
(2001). Regulation of acp1, encoding a non-aspartyl acid protease expressed during pathogenesis of Sclerotinia sclerotiorum. Microbiology
147: 717-726
[Abstract]
[Full Text]
-
Dalle, F., Franco, N., Lopez, J., Vagner, O., Caillot, D., Chavanet, P., Cuisenier, B., Aho, S., Lizard, S., Bonnin, A.
(2000). Comparative Genotyping of Candida albicans Bloodstream and Nonbloodstream Isolates at a Polymorphic Microsatellite Locus. J. Clin. Microbiol.
38: 4554-4559
[Abstract]
[Full Text]
-
Chen, J., Zhou, S., Wang, Q., Chen, X., Pan, T., Liu, H.
(2000). Crk1, a Novel Cdc2-Related Protein Kinase, Is Required for Hyphal Development and Virulence in Candida albicans. Mol. Cell. Biol.
20: 8696-8708
[Abstract]
[Full Text]
-
Davis, D., Edwards, J. E. Jr., Mitchell, A. P., Ibrahim, A. S.
(2000). Candida albicans RIM101 pH Response Pathway Is Required for Host-Pathogen Interactions. Infect. Immun.
68: 5953-5959
[Abstract]
[Full Text]
-
Mendoza-Lopez, M. R., Becerril-Garcia, C., Fattel-Facenda, L. V., Avila-Gonzalez, L., Ruiz-Tachiquin, M. E., Ortega-Lopez, J., Arroyo, R.
(2000). CP30, a Cysteine Proteinase Involved in Trichomonas vaginalis Cytoadherence. Infect. Immun.
68: 4907-4912
[Abstract]
[Full Text]
-
Odds, F. C., Van Nuffel, L., Gow, N. A. R.
(2000). Survival in experimental Candida albicans infections depends on inoculum growth conditions as well as animal host. Microbiology
146: 1881-1889
[Abstract]
[Full Text]
-
El Barkani, A., Kurzai, O., Fonzi, W. A., Ramon, A., Porta, A., Frosch, M., Mühlschlegel, F. A.
(2000). Dominant Active Alleles of RIM101 (PRR2) Bypass the pH Restriction on Filamentation of Candida albicans. Mol. Cell. Biol.
20: 4635-4647
[Abstract]
[Full Text]
-
Soong, T.-W., Yong, T.-F., Ramanan, N., Wang, Y.
(2000). The Candida albicans antiporter gene CNH1 has a role in Na+ and H+ transport, salt tolerance, and morphogenesis. Microbiology
146: 1035-1044
[Abstract]
[Full Text]
-
Soll, D. R.
(2000). The Ins and Outs of DNA Fingerprinting the Infectious Fungi. Clin. Microbiol. Rev.
13: 332-370
[Abstract]
[Full Text]
-
Tsuchimori, N., Sharkey, L. L., Fonzi, W. A., French, S. W., Edwards, J. E. Jr., Filler, S. G.
(2000). Reduced Virulence of HWP1-Deficient Mutants of Candida albicans and Their Interactions with Host Cells. Infect. Immun.
68: 1997-2002
[Abstract]
[Full Text]
-
Porta, A., Ramon, A. M., Fonzi, W. A.
(1999). PRR1, a Homolog of Aspergillus nidulans palF, Controls pH-Dependent Gene Expression and Filamentation in Candida albicans. J. Bacteriol.
181: 7516-7523
[Abstract]
[Full Text]
-
Ramon, A. M., Porta, A., Fonzi, W. A.
(1999). Effect of Environmental pH on Morphological Development of Candida albicans Is Mediated via the PacC-Related Transcription Factor Encoded by PRR2. J. Bacteriol.
181: 7524-7530
[Abstract]
[Full Text]
-
Fonzi, W. A.
(1999). PHR1 and PHR2 of Candida albicans Encode Putative Glycosidases Required for Proper Cross-Linking of beta -1,3- and beta -1,6-Glucans. J. Bacteriol.
181: 7070-7079
[Abstract]
[Full Text]
-
De Bernardis, F., Mondello, F., San Millàn, R., Pontòn, J., Cassone, A.
(1999). Biotyping and Virulence Properties of Skin Isolates of Candida parapsilosis. J. Clin. Microbiol.
37: 3481-3486
[Abstract]
[Full Text]
-
Calera, J. A., Zhao, X.-J., De Bernardis, F., Sheridan, M., Calderone, R.
(1999). Avirulence of Candida albicans CaHK1 Mutants in a Murine Model of Hematogenously Disseminated Candidiasis. Infect. Immun.
67: 4280-4284
[Abstract]
[Full Text]
-
Naglik, J. R., Newport, G., White, T. C., Fernandes-Naglik, L. L., Greenspan, J. S., Greenspan, D., Sweet, S. P., Challacombe, S. J., Agabian, N.
(1999). In Vivo Analysis of Secreted Aspartyl Proteinase Expression in Human Oral Candidiasis. Infect. Immun.
67: 2482-2490
[Abstract]
[Full Text]
-
Kurzai, O., Heinz, W. J., Sullivan, D. J., Coleman, D. C., Frosch, M., Mühlschlegel, F. A.
(1999). Rapid PCR Test for Discriminating between Candida albicans and Candida dubliniensis Isolates Using Primers Derived from the pH-Regulated PHR1 and PHR2 Genes of C. albicans. J. Clin. Microbiol.
37: 1587-1590
[Abstract]
[Full Text]
-
Lamb, T. M., Xu, W., Diamond, A., Mitchell, A. P.
(2001). Alkaline Response Genes of Saccharomyces cerevisiae and Their Relationship to the RIM101 Pathway. J. Biol. Chem.
276: 1850-1856
[Abstract]
[Full Text]